Immunology and Microbiology
Arthritis
81%
Leukocyte
81%
Osteoclast
81%
Fibril
81%
Chemotactic Factor
81%
Mesenchymal Stem Cell
81%
Chondrocyte
81%
Chemical Structure
81%
Fibrogenesis
81%
Osteoblast
81%
Chemotaxin
81%
Osteoarthritis
81%
Cell Surface
81%
Glucose Metabolism
81%
Artemin
81%
Inflammatory Arthritis
81%
Amyloidosis
81%
Glial Cell Line Derived Neurotrophic Factor
81%
Neutrophil
81%
Neural Cell Adhesion Molecule
6%
Structural Characteristics
6%
Carboxy Terminal Sequence
6%
Mitogen
6%
Peyer's Patch
6%
Tyrosine
6%
Amino Acid
6%
Signaling Mechanism
6%
Spinal Cord
6%
Persephin
6%
Neurturin
6%
Proteoglycan
6%
Lymphoid Tissue
6%
Nervous System Development
6%
Homeostasis
6%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
100%
Malignant Neoplasm
81%
Artemin
81%
Glial Cell Line Derived Neurotrophic Factor
81%
Arthritis
81%
Biological Marker
81%
Osteosarcoma
81%
Antiangiogenic Therapy
81%
Metastasis
75%
Chemotaxin
40%
Amyloidosis
40%
Osteoarthritis
40%
Chemotactic Factor
40%
Nonalcoholic Fatty Liver
40%
Cell Surface Receptor
40%
Rheumatoid Arthritis
40%
Inflammation
40%
Liver Cell Carcinoma
40%
Inflammatory Arthritis
40%
Recombinant Endostatin
23%
Tumor Growth
23%
Receptor
13%
Regorafenib
11%
Monoclonal Antibody
11%
Rivoceranib
11%
Bone Cancer
11%
Pazopanib
11%
Sorafenib
11%
Clinical Trial
11%
Vasculotropin
11%
Bevacizumab
11%
Protein Tyrosine Kinase Inhibitor
11%
Tumor Invasion
11%
Chemotherapy
11%
Mitogen Activated Protein Kinase
6%
Neuropathic Pain
6%
Amino Acid
6%
Furin
6%
Spinal Cord Injury
6%
Proteoheparan Sulfate
6%
Protein Tyrosine Kinase
6%
Nerve Cell Adhesion Molecule
6%
Syndecan 3
6%
Persephin
6%
Neurturin
6%
Medicine and Dentistry
Glial Cell Line Derived Neurotrophic Factor
81%
Antiangiogenic Therapy
81%
Osteosarcoma
81%
Artemin
81%
Cancer
81%
Nervous System Disorder
81%
Metastatic Carcinoma
34%
Recombinant Endostatin
23%
Angiogenesis
23%
Tumor Progression
23%
Diseases
18%
Mitogen-Activated Protein Kinase
13%
Receptor
13%
Tumor Invasion
11%
Regorafenib
11%
Pazopanib
11%
Rivoceranib
11%
Bevacizumab
11%
Osteoclast
11%
Vasculotropin
11%
Neoadjuvant Chemotherapy
11%
Osteoblast
11%
Tyrosine-Kinase Inhibitor
11%
Monoclonal Antibody
11%
Sorafenib
11%
Clinical Trial
11%
Bone Cancer
11%
Homeostasis
6%
Gut
6%
Signaling Mechanism
6%
Lymphatic Tissue
6%
Protein Tyrosine Kinase
6%
Proteoheparan Sulfate
6%
Amino Acid
6%
Peyer's Patch
6%
Neurogenesis
6%
Kinase
6%
Neuropathic Pain
6%
Nerve Cell Adhesion Molecule
6%
Carboxy Terminal Sequence
6%
Neurturin
6%
Spinal Cord Injury
6%
Syndecan 3
6%
Persephin
6%
Furin
6%